Dr. Reddy’s Laboratories

Dr. Reddy’s Laboratories

Integrated global pharmaceutical company.

Launch date
Employees
Market cap
€12.1b
Enterprise valuation
€11.4b (Public information from Sep 2024)
Hyderabad Telangana (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
INR2021202220232024202520262027
Revenues189.7b214.4b245.9b279.2b313.2b336.9b325.6b
% growth9 %13 %15 %14 %12 %8 %(3 %)
EBITDA48.9b52.6b75.1b82.6b87.7b91.6b76.6b
% EBITDA margin26 %25 %31 %30 %28 %27 %24 %
Profit19.1b23.6b45.1b55.7b57.0b59.9b49.5b
% profit margin10 %11 %18 %20 %18 %18 %15 %
EV / revenue3.9x3.3x2.9x3.4x3.5x3.2x3.1x
EV / EBITDA15.3x13.4x9.6x11.6x12.7x11.7x13.4x
R&D budget16.5b17.5b19.4b22.9b---
R&D % of revenue9 %8 %8 %8 %---
  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO

$6.0m

Post IPO Equity
*

N/A

Post IPO Equity
Total Funding-

Recent News about Dr. Reddy’s Laboratories

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Dr. Reddy’s Laboratories

Edit
Hatchtech
ACQUISITION by Dr. Reddy’s Laboratories Nov 2015
OctoPlus
ACQUISITION by Dr. Reddy’s Laboratories Oct 2012
MenoLabs
ACQUISITION by Dr. Reddy’s Laboratories Jan 2024
Nimbus Health
ACQUISITION by Dr. Reddy’s Laboratories Feb 2022